Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA‐A24‐positive pancreatic adenocarcinoma

The prognosis of advanced pancreatic adenocarcinoma is still extremely poor. This study sought to determine the efficacy of, and immunological response to, peptide vaccination therapy in patients with this disease. In this multicenter randomized phase II study, patients with advanced pancreatic aden...

Descripción completa

Detalles Bibliográficos
Autores principales: Shima, Hiroaki, Tsurita, Giichiro, Wada, Satoshi, Hirohashi, Yoshihiko, Yasui, Hiroshi, Hayashi, Hiroshi, Miyakoshi, Takashi, Watanabe, Kazue, Murai, Aiko, Asanuma, Hiroko, Tokita, Serina, Kubo, Terufumi, Nakatsugawa, Munehide, Kanaseki, Takayuki, Tsukahara, Tomohide, Nakae, Yutaka, Sugita, Osamu, Ito, Yoichi M., Ota, Yasunori, Kimura, Yasutoshi, Kutomi, Goro, Hirata, Koichi, Mizuguchi, Toru, Imai, Kohzoh, Takemasa, Ichiro, Sato, Noriyuki, Torigoe, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676125/
https://www.ncbi.nlm.nih.gov/pubmed/31218770
http://dx.doi.org/10.1111/cas.14106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676125/
https://www.ncbi.nlm.nih.gov/pubmed/31218770
http://dx.doi.org/10.1111/cas.14106

Ejemplares similares